- Home
- EDSA vs ALCE Comparison
EDSA vs ALCE Comparison
Compare EDSA & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ALCE
- Stock Information
- Founded
- EDSA 2015
- ALCE 2019
- Country
- EDSA Canada
- ALCE United States
- Employees
- EDSA N/A
- ALCE N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- EDSA Health Care
- ALCE Utilities
- Exchange
- EDSA Nasdaq
- ALCE Nasdaq
- Market Cap
- EDSA 13.7M
- ALCE 13.9M
- IPO Year
- EDSA N/A
- ALCE N/A
- Fundamental
- Price
- EDSA $4.28
- ALCE $0.15
- Analyst Decision
- EDSA Strong Buy
- ALCE
- Analyst Count
- EDSA 2
- ALCE 0
- Target Price
- EDSA $39.00
- ALCE N/A
- AVG Volume (30 Days)
- EDSA 8.9K
- ALCE 99.6K
- Earning Date
- EDSA 08-09-2024
- ALCE 11-15-2024
- Dividend Yield
- EDSA N/A
- ALCE N/A
- EPS Growth
- EDSA N/A
- ALCE N/A
- EPS
- EDSA N/A
- ALCE N/A
- Revenue
- EDSA N/A
- ALCE N/A
- Revenue This Year
- EDSA N/A
- ALCE N/A
- Revenue Next Year
- EDSA N/A
- ALCE N/A
- P/E Ratio
- EDSA N/A
- ALCE N/A
- Revenue Growth
- EDSA N/A
- ALCE N/A
- 52 Week Low
- EDSA $2.46
- ALCE $0.14
- 52 Week High
- EDSA $8.33
- ALCE $10.89
- Technical
- Relative Strength Index (RSI)
- EDSA 45.00
- ALCE 27.23
- Support Level
- EDSA $4.20
- ALCE $0.15
- Resistance Level
- EDSA $5.00
- ALCE $0.20
- Average True Range (ATR)
- EDSA 0.23
- ALCE 0.02
- MACD
- EDSA 0.01
- ALCE 0.00
- Stochastic Oscillator
- EDSA 14.29
- ALCE 13.79
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.